bpc-157 clinicaltrials.gov nct Human trials exploring anti-aging medicines BPC-157 FDA Approval Status: Is
BPC 157 FDA Approval Status: Is It Approved for Human Use? Cachexia, the muscle wasting syndrome that affects 80% of cancer patients, has long been considered untreatable. For pancreatic cancer patients, it's one of the most devastating parts of the disease, and there are BPC 157 Injectable Peptide for Healing & Recovery Australian Clinical Trials tm267368d1_6kimg023.jpg
Pay in 4 interest-free payments of $5.66 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6



